Impact and Cost-Effectiveness of Alternative Human Papillomavirus Vaccines for Preadolescent Girls in Mozambique: A Modelling Study.
Mozambique
UNIVAC
cervical cancer
cost-effectiveness
modelling
papillomavirus
vaccination
Journal
Vaccines
ISSN: 2076-393X
Titre abrégé: Vaccines (Basel)
Pays: Switzerland
ID NLM: 101629355
Informations de publication
Date de publication:
02 Jun 2023
02 Jun 2023
Historique:
received:
30
01
2023
revised:
14
03
2023
accepted:
16
03
2023
medline:
28
6
2023
pubmed:
28
6
2023
entrez:
28
6
2023
Statut:
epublish
Résumé
Mozambique has one of the highest rates of cervical cancer in the world. Human papillomavirus (HPV) vaccination was introduced in 2021. This study evaluated the health and economic impact of the current HPV vaccine (GARDASIL
Identifiants
pubmed: 37376447
pii: vaccines11061058
doi: 10.3390/vaccines11061058
pmc: PMC10304296
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Program for Appropriate Technology in Health
ID : GAT.2111-01707508-SUB
Références
Saudi Med J. 2022 May;43(5):538
pubmed: 35537734
Lancet Glob Health. 2015 Nov;3(11):e712-23
pubmed: 26475018
J Infect Dis. 2021 Sep 30;224(12 Suppl 2):S367-S378
pubmed: 34590141
Lancet. 2020 Feb 22;395(10224):575-590
pubmed: 32007141
Eur J Cancer Prev. 2019 Jul;28(4):338-343
pubmed: 30020115
PLoS One. 2019 Jun 6;14(6):e0217331
pubmed: 31170193
Lancet. 2007 Sep 22;370(9592):1031; author reply 1032-3
pubmed: 17889237
J Natl Cancer Inst. 2020 Feb 1;112(2):145-153
pubmed: 31086947
Int J Gynaecol Obstet. 2017 Jul;138 Suppl 1:47-56
pubmed: 28691334
Value Health Reg Issues. 2016 Sep;10:1-6
pubmed: 27881270
BMC Womens Health. 2021 Dec 18;21(1):419
pubmed: 34922503
N Engl J Med. 2007 May 10;356(19):1915-27
pubmed: 17494925
Bull World Health Organ. 2016 Dec 1;94(12):925-930
pubmed: 27994285
Cancer. 2017 Sep 1;123(17):3253-3260
pubmed: 28472550
Implement Sci. 2022 Jan 27;17(1):10
pubmed: 35086538
Lancet. 2009 Jul 25;374(9686):301-14
pubmed: 19586656
Clin Infect Dis. 2021 Mar 1;72(5):e103-e111
pubmed: 33249475
NEJM Evid. 2022 Jun;1(5):EVIDoa2100056
pubmed: 35693874
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Int J Gynecol Cancer. 2020 Sep;30(9):1292-1297
pubmed: 32737122
Lancet Infect Dis. 2017 Dec;17(12):1293-1302
pubmed: 28965955
BMC Public Health. 2019 Oct 29;19(1):1406
pubmed: 31664976
Clin Vaccine Immunol. 2015 Apr;22(4):361-73
pubmed: 25651922
Health Policy Plan. 2012 May;27 Suppl 2:ii5-16
pubmed: 22513732
Lancet Oncol. 2012 Jan;13(1):100-10
pubmed: 22075170
J Infect Dis. 2009 Apr 1;199(7):926-35
pubmed: 19236279
Vaccine. 2020 Feb 5;38(6):1352-1362
pubmed: 31870571
CA Cancer J Clin. 2020 Sep;70(5):321-346
pubmed: 32729638
J Int AIDS Soc. 2012 Jun 18;15(2):17406
pubmed: 22713260
Vaccine. 2022 Mar 31;40 Suppl 1:A85-A93
pubmed: 34303563
Int J Cancer. 2020 Dec 1;147(11):3037-3048
pubmed: 32449157
PLoS One. 2021 Apr 15;16(4):e0250113
pubmed: 33857233
Cost Eff Resour Alloc. 2021 Feb 4;19(1):7
pubmed: 33541364
BMC Public Health. 2019 Aug 1;19(1):1031
pubmed: 31370810